You've noticed a mole that looks different from the others, perhaps it has changed colour, started itching or developed an uneven edge. Your first thought may be, “Will someone remove the whole thing, or just take a sample?” In the UK, that question matters because a biopsy on a mole suspected of being melanoma usually means complete removal of the lesion, followed by laboratory examination.
The pathway can feel unclear, especially when we're unsure whether our GP will perform the procedure or refer us to dermatology. We'll explain what prompts investigation, which biopsy techniques are used, why full-thickness excision is usually preferred, what recovery involves and how the report guides the next step.
When a Mole Warrants a Closer Look
We often notice a mole while getting dressed, showering or checking a photograph. It may not look dramatically different, but one edge seems less regular, or a familiar mark appears darker than before. That uncertainty can be unsettling, yet it's a good reason to arrange a professional assessment rather than trying to judge the lesion from a single glance.
A new or changing mole deserves attention, particularly when we notice differences in size, shape, colour, sensation or surface. A mole that bleeds, oozes, becomes inflamed or develops persistent itching should also be examined. These signs don't prove melanoma, but they give a clinician a reason to look more closely.
A clinical assessment may involve a visual examination, a medical history and dermoscopy, which allows a trained practitioner to inspect structures beneath the surface. If the lesion remains suspicious, the next step may be referral through the suspected-cancer pathway and an excision biopsy.
Reassuring perspective: A recommendation for biopsy is a request for a definite answer, not a diagnosis of cancer.
We should also separate a potentially suspicious pigmented lesion from a harmless skin growth that resembles a mole. Understanding the difference between a skin tag, mole and wart can help us describe what we've noticed, but self-comparison can't replace an examination.
At Skin Revision, Jacqui Bannister, our multi award-winning paramedical skin therapist with more than 20 years of experience, works alongside Sarra Kourdi, our advanced skin therapist. Our role is to assess appropriate non-suspicious concerns and help identify when a lesion needs medical review. Suspected melanoma belongs within the NHS clinical pathway.
How Doctors Decide a Mole Needs a Biopsy
If a mole looks different from its neighbours, a clinician assesses the overall pattern rather than making a decision from one isolated feature. The ABCDE framework helps us describe what has changed. Clinicians may then use the more specific weighted 7-point checklist, followed by dermoscopy and a decision about the most suitable UK referral route.
The ABCDE framework
- Asymmetry: One half of the mole does not resemble the other.
- Border: The edge appears irregular, scalloped or poorly defined.
- Colour: The lesion contains uneven shades, such as brown, black or pink.
- Diameter: The largest measurement is at least 7 mm, according to the NICE suspected cancer pathway summary.
- Evolving: The mole is changing in size, shape or colour.
Diameter is a prompt, not a pass or fail rule. A smaller lesion that is changing may still need assessment, while a larger stable mark may be harmless.
The weighted 7-point checklist
The clinician's checklist gives 2 points for each major feature:
- Change in size
- Irregular shape
- Irregular colour
Smaller features receive 1 point, including a diameter of at least 7 mm, inflammation, oozing, a change in sensation and another minor feature listed in the guidance. A score of 3 or more supports referral through the suspected cancer pathway. Dermoscopy that suggests melanoma also meets urgent referral criteria, as set out in the NICE referral criteria.
NICE specifies a suspected-cancer pathway appointment within 2 weeks when these criteria are met. This does not guarantee a biopsy on the same day. It means the concern should be assessed promptly by the appropriate service, which may decide whether primary-care biopsy or specialist referral is more suitable.
Biopsy Types and Why Excision Is Usually Preferred
A biopsy is not one single procedure. The choice affects how much of a mole the pathologist can assess, so a suspicious lesion is usually approached differently from a harmless-looking mark. For a small lesion that could be melanoma, UK guidance generally favours full-thickness excision biopsy, because examining the entire mole shows both its structure and its relationship with nearby skin.
Comparing the main approaches
An excision biopsy removes the whole mole with a narrow rim of normal skin. SIGN describes the optimal specimen as complete excision with a 2 mm surround of normal skin and a cuff of fat (SIGN cutaneous melanoma guidance). Older UK guidance described a full-thickness specimen with a 2 to 5 mm lateral margin and subdermal fat (British Journal of Dermatology guidance).
An incisional biopsy removes only part of the lesion. It may be chosen if the mole is very large, extends into deeper tissue, or sits in a cosmetically sensitive area where complete removal would be difficult as the first procedure.
A punch biopsy uses a circular instrument to remove a full-thickness core. It can show depth, but it may miss the most concerning part of an uneven lesion or fail to show its full architecture. For that reason, routine punch biopsy is not recommended for a suspicious pigmented lesion when complete excision is practical.
A shave biopsy removes the upper skin layers. UK melanoma guidance considers a superficial shave biopsy unsuitable for a suspicious pigmented lesion because cutting through the lesion can leave the depth uncertain and interfere with staging.
Why depth changes the plan
The pathologist measures Breslow thickness, the distance melanoma has extended into the skin. A partial or superficial sample may give an incomplete measurement, which can affect staging and the treatment plan. The aim is therefore to preserve the information needed for the next decision, not just to remove the visible spot quickly.
If complete excision is not practical initially, SIGN advises an incisional or punch biopsy from the most suspicious area. That is a considered exception, not a reason to use a superficial shave biopsy for convenience.
What Happens During the Procedure
The appointment usually begins with a discussion about why the lesion needs removal, what technique is proposed and whether stitches will be needed. We should use this time to ask where the mole will be sent, when results are expected and who will explain the report.
The clinician cleans the skin and injects local anaesthetic. The injection can sting briefly, but once the area is numb we should feel pressure and movement rather than sharp pain. The lesion is then removed, usually with a narrow margin when melanoma is a concern, and the wound may be closed with stitches.
The procedure itself is generally straightforward, but its duration varies with the lesion's site, size and the closure required. We can usually plan to leave with a dressing and written wound-care advice, although we should follow the specific instructions given by the treating team.
Where the tissue goes
The removed tissue is placed in a specimen container, commonly containing formalin, and sent to a histopathology laboratory. A pathologist examines the tissue under a microscope and records the features that determine the diagnosis and, if melanoma is present, its stage.
The practical details matter after we leave. We should keep the dressing and wound care instructions available, avoid pulling at stitches and contact the treating service if bleeding doesn't settle with firm pressure or if redness, swelling, discharge or pain is worsening.
For a plain-language explanation of the removal process, our guide to the mole removal procedure may help us understand the difference between cosmetic lesion removal and a medically directed biopsy.
Recovery, Results and What the Report Means
After an excision biopsy, we'll have a small wound that may be closed with stitches. The treating clinician will explain when the dressing should be changed, how to clean the area and when stitches need removal. We shouldn't apply cosmetic products directly to the wound unless the medical team says it's appropriate.
Mild tenderness, bruising or a small amount of oozing can occur, but symptoms that become more intense need attention. We should contact the treating service promptly if bleeding continues, the area becomes increasingly hot or swollen, pain escalates, pus develops or we feel unwell.
Waiting for the report
One UK NHS trust states that melanoma biopsy results typically take about 4 to 6 weeks (North Bristol NHS Trust melanoma information). The timing can vary with laboratory processing, specialist review and the complexity of the findings, so we should ask the team how results will be communicated.
A pathology report may include:
- Diagnosis: Whether the lesion is benign or melanoma, along with the specific classification.
- Breslow thickness: The measured depth of an invasive melanoma.
- Ulceration: Whether the surface skin is broken over the melanoma.
- Mitotic activity: A description of cell division that may contribute to risk assessment.
- Margins: Whether the lesion appears fully removed in the biopsy specimen.
A report can contain unfamiliar terminology, so reviewing a sample medical report from Patient Talker LLC may help us recognise the general format, although it can't interpret our own result.
Why the numbers matter
NICE uses biopsy-derived Breslow thickness when deciding whether further management should be considered. Sentinel lymph node biopsy isn't offered for stage IA melanoma, but it is considered for melanomas thicker than 1.0 mm, or for thickness between 0.8 mm and 1.0 mm when high-risk features are present, including ulceration, lymphovascular invasion or a mitotic index of 2 or more (NICE melanoma recommendations).
| Breslow thickness | Typical next step |
|---|---|
| Less than 0.8 mm | Management depends on the full report and clinical stage |
| 0.8 to 1.0 mm with high-risk features | Sentinel lymph node biopsy may be considered |
| More than 1.0 mm | Sentinel lymph node biopsy may be considered |
The table is a guide to how thickness influences discussion, not a substitute for the specialist's interpretation of the complete report.
GP Biopsy, Specialist Referral and the UK Pathway
Many people assume that a GP will either remove a suspicious mole immediately or reassure us without further action. The actual pathway is more nuanced. The GP may assess the lesion, use referral criteria and decide whether an in-practice procedure is suitable or whether specialist input is safer.
Scottish guidance explicitly advises GPs to refer urgently rather than biopsy suspicious lesions in primary care, and it states that superficial shave biopsy is inappropriate for suspicious pigmented lesions (Scottish suspected-cancer referral guidance). Other UK settings may have different arrangements, but suspected melanoma is generally managed with specialist oversight when the lesion is complex or the diagnosis is a genuine concern.
What affects the decision
A GP or specialist may consider:
- Lesion size: A large mole may need a planned approach rather than immediate complete removal.
- Location: The face, nail unit or an acral site can require specialist planning.
- Clinical appearance: Irregular colour, evolving structure or concerning dermoscopic features can change the referral decision.
- Ability to remove it completely: If complete excision isn't practical, the most suspicious area may be sampled using an appropriate full-thickness technique.
The straightforward rule is this: if melanoma is a real possibility, we should expect the NHS pathway to prioritise appropriate specialist assessment rather than a quick superficial sample. A referral isn't a delay for its own sake. It helps protect the tissue needed for accurate diagnosis and staging.
For non-suspicious concerns, our mole check service can provide assessment and written dermatology reporting, with onward advice where further medical evaluation is indicated. It doesn't replace the NHS suspected-cancer pathway or perform diagnostic treatment for suspected melanoma.
Practical Takeaways and When to Book a Consultation
A changing mole shouldn't be ignored, but it also doesn't need to trigger panic. We can record what has changed, avoid picking at the area and arrange an assessment with a GP or an appropriate skin professional. A clear photograph and a note of when the change began can help us describe the history accurately.
The key questions are practical:
- Has the mole evolved? Changes in size, shape or colour are important.
- Does it look different from our other moles? The “ugly duckling” idea can prompt useful discussion, even though it isn't a diagnosis.
- Is there bleeding, oozing, inflammation or altered sensation? These features should be reported.
- Could the site make complete removal difficult? Lesions on the face, nail unit or acral skin may need specialist planning.
- Has a clinician recommended referral? We shouldn't delay an NHS assessment while seeking cosmetic treatment.
When melanoma is suspected, a UK biopsy on a mole usually means excision of the whole lesion, with a narrow margin and full thickness where feasible. Partial sampling is reserved for situations where complete removal isn't practical, and superficial shave biopsy isn't the appropriate approach for a suspicious pigmented lesion.
Where Skin Revision fits
Skin Revision can assess non-suspicious moles and benign lesions such as skin tags, milia and warts, then provide guidance about whether medical review is needed. We don't diagnose suspected melanoma or replace urgent NHS referral. We also don't offer laser therapy, laser resurfacing, ablative lasers, subcision, punch excision or TCA CROSS.
For suitable cosmetic or benign concerns, our wider treatment options include CryoPen, Thermavein, LED therapy, microneedling, chemical peels, HydraFacial, Plaxel Plasma, SQT bio-microneedling, DMK facials and AlumierMD skincare. We also offer Botox, dermal fillers, Profhilo and polynucleotides, but these treatments aren't appropriate for an unassessed suspicious pigmented lesion.
Jacqui Bannister leads the clinic with more than 20 years of experience, supported by Sarra Kourdi. We're based at 9a Burkes Parade, Station Road, Beaconsfield HP9 1NN, where we can discuss a benign skin concern calmly and explain when NHS care is the correct route.
We support clients from Beaconsfield, Gerrards Cross, Amersham, High Wycombe, Marlow and Slough, as well as communities across wider Buckinghamshire, Berkshire and Hertfordshire. If a mole is changing, bleeding or otherwise concerning, contact your GP or the suspected-cancer service first. If the concern appears non-suspicious and you'd like professional guidance, book a consultation with our team.
For a non-suspicious mole, skin tag, milia or wart, visit Skin Revision to arrange a consultation and discuss the most appropriate next step. If our assessment suggests medical investigation, we'll explain why specialist or NHS care is needed rather than treating the lesion cosmetically.
